5-[4-[(2-cyclopropylimidazo[5,1-b][1,3]thiazol-3-yl)-hydroxymethyl]triazol-1-yl]-1,3-dihydrobenzimidazol-2-one
C18H15N7O2S — CID 142621246
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-[4-[(2-cyclopropylimidazo[5,1-b][1,3]thiazol-3-yl)-hydroxymethyl]triazol-1-yl]-1,3-dihydrobenzimidazol-2-one
5-[4-[(2-cyclopropylimidazo[5,1-b][1,3]thiazol-3-yl)-hydroxymethyl]triazol-1-yl]-1,3-dihydrobenzimidazol-2-one (PubChem CID 142621246) has the molecular formula C18H15N7O2S and a molecular weight of 393.43 g/mol. Its IUPAC name is 5-[4-[(2-cyclopropylimidazo[5,1-b][1,3]thiazol-3-yl)-hydroxymethyl]triazol-1-yl]-1,3-dihydrobenzimidazol-2-one.
Molecular Properties
| Compound Name | 5-[4-[(2-cyclopropylimidazo[5,1-b][1,3]thiazol-3-yl)-hydroxymethyl]triazol-1-yl]-1,3-dihydrobenzimidazol-2-one |
|---|---|
| PubChem CID | 142621246 |
| Molecular Formula | C18H15N7O2S |
| Molecular Weight | 393.43 g/mol |
| Exact Mass | 393.10 |
| IUPAC Name | 5-[4-[(2-cyclopropylimidazo[5,1-b][1,3]thiazol-3-yl)-hydroxymethyl]triazol-1-yl]-1,3-dihydrobenzimidazol-2-one |
| SMILES | O=c1[nH]c2ccc(-n3cc(C(O)c4c(C5CC5)sc5cncn45)nn3)cc2[nH]1 |
| InChI | InChI=1S/C18H15N7O2S/c26-16(15-17(9-1-2-9)28-14-6-19-8-24(14)15)13-7-25(23-22-13)10-3-4-11-12(5-10)21-18(27)20-11/h3-9,16,26H,1-2H2,(H2,20,21,27) |
| InChIKey | VZTWLVYINYXWLU-UHFFFAOYSA-N |
| XLogP | 2.11 |
| TPSA | 116.89 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 28 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 393.43 |
| LogP ≤ 5 | 2.11 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 142621246 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.